206 results on '"Haymart, Brian"'
Search Results
2. Prevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event
3. Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study
4. Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement
5. Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation
6. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin
7. Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
8. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series
9. Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes
10. Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI 2) registry.
11. Unexplained Hematuria in Direct Oral Anticoagulant Use: A Single-Center Retrospective Case Series
12. Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism
13. Abstract 13427: Bleeding in Morbidly Obese Patients Treated With Direct Oral Anticoagulants Compared to Warfarin: The Michigan Anticoagulation Quality Improvement Initiative Experience
14. Periprocedural bridging anticoagulation in patients with venous thromboembolism: A registry‐based cohort study
15. Root Cause Analysis of Adverse Events in an Outpatient Anticoagulation Management Consortium
16. Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants
17. Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “Real-World” Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials
18. Mind the gap: results of a multispecialty survey on coordination of care for peri-procedural anticoagulation
19. Prescribing trends of atrial fibrillation patients who switched from warfarin to a direct oral anticoagulant
20. Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin
21. Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
22. The Predictive Ability of the CHADS2 and CHA2DS2-VASc Scores for Bleeding Risk in Atrial Fibrillation: The MAQI2 Experience
23. Periprocedural Bridging Anticoagulation: Measuring the Impact of a Clinical Trial on Care Delivery
24. Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant
25. Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation
26. Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
27. Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients.
28. The changing characteristics of atrial fibrillation patients treated with warfarin
29. Association of adding antiplatelet therapy to warfarin for management of venous thromboembolism with bleeding and other adverse events
30. sj-pdf-1-vmj-10.1177_1358863X221089333 – Supplemental material for Association of adding antiplatelet therapy to warfarin for management of venous thromboembolism with bleeding and other adverse events
31. 474 THE EFFECT OF A MULTICOMPONENT INTERVENTION ON GASTROINTESTINAL BLEEDING RISK IN PATIENTS PRESCRIBED WARFARIN: THE ANTICOAGULATION WITH ENHANCED GASTROINTESTINAL SAFETY (AEGIS) RANDOMIZED TRIAL
32. Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
33. Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
34. Abstract 11055: Length of Anticoagulation Treatment in Provoked VTE - Lessons from the Maqi 2 Collaborative
35. Abstract 11915: Less Aspirin, Less Bleeding for Patients on Chronic Warfarin Anticoagulation for Atrial Fibrillation and/or Venous Thromboembolic Disease
36. Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin for Atrial Fibrillation and/or Venous Thromboembolic Disease
37. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
38. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series
39. Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures
40. sj-pdf-1-jpp-10.1177_08971900211064189 ��� Supplemental Material for Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
41. sj-pdf-2-jpp-10.1177_08971900211064189 ��� Supplemental Material for Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
42. sj-pdf-4-jpp-10.1177_08971900211064189 ��� Supplemental Material for Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
43. sj-pdf-3-jpp-10.1177_08971900211064189 ��� Supplemental Material for Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients
44. Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study
45. A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
46. Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication
47. Reduction in epistaxis and emergency department visits in patients taking warfarin after implementation of an education program
48. Correcting Inappropriate Prescribing of Direct Oral Anticoagulants: A Population Health Approach
49. 10.1177_1358863X18815971_Supplemental_Material – Supplemental material for Missed opportunities to prevent upper GI hemorrhage: The experience of the Michigan Anticoagulation Quality Improvement Initiative
50. A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.